Alpha 2.0
Login Register
» Authors » Nicolas Troillet

Nicolas Troillet

Explore the profile of Nicolas Troillet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 607
Followers 0
Related Specialties
General Medicine
Infectious Diseases
General Surgery
Top 10 Co-Authors
Rami Sommerstein
Jonas Marschall
Andreas Widmer
Danielle Vuichard-Gysin
Stephan Harbarth
Carlo Balmelli
Marie-Christine Eisenring
Andrew Atkinson
Peter W Schreiber
Andreas F Widmer
Published In
Rev Med Suisse
Swiss Med Wkly
Antimicrob Resist Infect Control
Infect Control Hosp Epidemiol
Ann Surg
Affiliations
Soon will be listed here.
Recent Articles
1.
In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza: a retrospective, nationwide cohort study in Switzerland
Grant R, de Kraker M, Buetti N, Jackson H, Abbas M, Sobel J, et al.
Clin Infect Dis . 2024 Nov; PMID: 39535247
Background: As COVID-19 is integrated into existing infectious disease control programs, it is important to understand the comparative clinical impact of COVID-19 and other respiratory diseases. Methods: We conducted a...
2.
Swiss COVID-19 hospital surveillance: an in-depth analysis of the factors associated with hospital readmission dynamics in community-acquired COVID-19 cases
Vancauwenberghe L, Roelens M, Urbini L, Iten A, Zanella M, Nwosu K, et al.
Swiss Med Wkly . 2024 Oct; 154:3773. PMID: 39462475
Background: The COVID-19 pandemic has placed unprecedented pressure on hospitals worldwide. In such a context of tension in healthcare systems, efficiently allocating hospital resources is a crucial aspect of crisis...
3.
Association of institutional masking policies with healthcare-associated SARS-CoV-2 infections in Swiss acute care hospitals during the BA.4/5 wave (CH-SUR study): a retrospective observational study
Dorr T, Gusewell S, Flury D, Suveges M, Gaza Valera C, Botero-Mesa S, et al.
Antimicrob Resist Infect Control . 2024 Jun; 13(1):64. PMID: 38886813
Background: In the initial phase of the SARS-CoV-2 pandemic, masking has been widely accepted in healthcare institutions to mitigate the risk of healthcare-associated infection. Evidence, however, is still scant and...
4.
Surgical Antimicrobial Prophylaxis in Low-Risk Cholecystectomies is Associated with Fewer Surgical Site Infections: Nationwide Cohort Study in Switzerland
Florinett L, Widmer A, Troillet N, Beldi G, von Flue M, Harbarth S, et al.
Ann Surg . 2024 Jun; PMID: 38881461
Objective: To assess whether administration of surgical antimicrobial prophylaxis (SAP) versus absence of SAP is associated with a decreased risk of surgical site infections (SSI) after low-risk cholecystectomies (LR-CCE). Summary...
5.
Association between the introduction of a national targeted intervention program and the incidence of surgical site infections in Swiss acute care hospitals
Eder M, Sommerstein R, Szelecsenyi A, Schweiger A, Schlegel M, Atkinson A, et al.
Antimicrob Resist Infect Control . 2023 Nov; 12(1):134. PMID: 37996935
Background: In Switzerland, the national surgical site infection (SSI) surveillance program showed a modest decrease in SSI rates for different procedures over the last decade. The study aimed to determine...
6.
Treatment effect of remdesivir on the mortality of hospitalised COVID-19 patients in Switzerland across different patient groups: a tree-based model analysis
Estill J, Venkova-Marchevska P, Gunthard H, Botero-Mesa S, Thiabaud A, Roelens M, et al.
Swiss Med Wkly . 2023 Sep; 153:40095. PMID: 37769356
Aims Of The Study: Remdesivir has shown benefits against COVID-19. However, it remains unclear whether, to what extent, and among whom remdesivir can reduce COVID-19-related mortality. We explored whether the...
7.
Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study
Bielicki I, Schmid H, Atkinson A, Kahlert C, Berger C, Troillet N, et al.
Antimicrob Resist Infect Control . 2023 Sep; 12(1):106. PMID: 37749585
Objective: We aimed to evaluate the association between post-appendectomy SSI rates and the two most commonly used regimens for perioperative antimicrobial prophylaxis in Swiss children. Methods: We conducted a retrospective...
8.
Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
Stavropoulou E, Atkinson A, Eisenring M, Fux C, Marschall J, Senn L, et al.
Antimicrob Resist Infect Control . 2023 Sep; 12(1):105. PMID: 37726838
Objective: To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime plus metronidazole (C + M) for preventing surgical site infections (SSI) in colorectal surgery. Background: Given their spectra that...
9.
Timing of Cefuroxime Surgical Antimicrobial Prophylaxis and Its Association With Surgical Site Infections
Sommerstein R, Troillet N, Harbarth S, de Kraker M, Vuichard-Gysin D, Kuster S, et al.
JAMA Netw Open . 2023 Jun; 6(6):e2317370. PMID: 37289455
Importance: World Health Organization guidelines recommend administering surgical antimicrobial prophylaxis (SAP), including cefuroxime, within 120 minutes prior to incision. However, data from clinical settings supporting this long interval is limited....
10.
Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland
Portmann L, de Kraker M, Frohlich G, Thiabaud A, Roelens M, Schreiber P, et al.
JAMA Netw Open . 2023 Feb; 6(2):e2255599. PMID: 36790812
Importance: With the ongoing COVID-19 pandemic, it is crucial to assess the current burden of disease of community-acquired SARS-CoV-2 Omicron variant in hospitalized patients to tailor appropriate public health policies....